Ogivri – Trastuzumab uses, dose and side effects
Ogivri contains the active substance trastuzumab, which is a monoclonal antibody . Monoclonal antibodies are attached to specific proteins or antigens . Trastuzumab is designed to bind selectively to an antigen called human epidermal growth factor receptor 2 ( HER2 ). HER2 is found in large amounts on the surface of certain cancer cells ( HER2 -positive cancer) and then stimulates cell growth. When Ogivri binds to HER2 , the growth of the cancer cells is stopped and it leads to their death.
Read More